| calcium channel, voltage-dependent, L type, alpha 1D subunit |
BENZETHONIUM CHLORIDE |
Calcium Channel Type L, Benzothiazepine |
99% |
1.403uM |
1.247uM |
View
|
| opioid receptor, sigma 1 |
CINNARIZINE |
Sigma1 |
95% |
.04uM |
.017uM |
View
|
| opioid receptor, sigma 1 |
PROPARACAINE |
Sigma1 |
94% |
.238uM |
.1uM |
View
|
| melanocortin 4 receptor |
COLISTIN |
Melanocortin MC4 |
94% |
.841uM |
.809uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
FLUOXETINE |
Calcium Channel Type L, Phenylalkylamine |
94% |
1.126uM |
1.095uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
FLUOXETINE |
Calcium Channel Type L, Phenylalkylamine |
94% |
1.126uM |
1.095uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
FLUOXETINE |
Calcium Channel Type L, Phenylalkylamine |
94% |
1.126uM |
1.095uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
FLUOXETINE |
Calcium Channel Type L, Phenylalkylamine |
94% |
1.126uM |
1.095uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
FLUOXETINE |
Calcium Channel Type L, Phenylalkylamine |
94% |
1.126uM |
1.095uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
ECONAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
5.453uM |
3.506uM |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
ECONAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
5.453uM |
3.506uM |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
ECONAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
5.453uM |
3.506uM |
View
|
| adrenergic receptor, beta 1 |
ECONAZOLE |
Adrenergic beta1 |
90% |
12.821uM |
7.404uM |
View
|
| adrenergic, beta-1-, receptor |
ECONAZOLE |
Adrenergic beta1 |
90% |
12.821uM |
7.404uM |
View
|
| monoamine oxidase A |
BENZO[A]PYRENE |
Monoamine Oxidase MAOA |
90% |
5.972uM |
NoneNone |
View
|
| monoamine oxidase A |
BENZO[A]PYRENE |
Monoamine Oxidase MAOA |
90% |
5.972uM |
NoneNone |
View
|
| adrenergic receptor, alpha 2a |
CIGLITAZONE |
Adrenergic alpha2A |
90% |
16.551uM |
6.207uM |
View
|
| cholinergic receptor, muscarinic 1 |
SULCONAZOLE |
Muscarinic M1 |
90% |
3.675uM |
.885uM |
View
|
| Protein-tyrosine kinase, Fyn |
DIETHYLSTILBESTROL |
Protein Tyrosine Kinase, Fyn |
90% |
14.233uM |
NoneNone |
View
|
| adrenergic receptor, alpha 2b |
DIETHYLSTILBESTROL |
Adrenergic alpha2C |
90% |
15.151uM |
2.201uM |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
DIETHYLSTILBESTROL |
Adrenergic alpha2C |
90% |
15.151uM |
2.201uM |
View
|
| mu-opioid receptor MOR |
DIETHYLSTILBESTROL |
Opiate mu |
90% |
5.778uM |
2.345uM |
View
|
| dopamine receptor D3 |
AMIFOSTINE |
Dopamine D3 |
90% |
1.929uM |
.655uM |
View
|
| sodium channel, voltage-gated, type IX, alpha |
AMITRIPTYLINE |
Sodium Channel, Site 2 |
90% |
2.288uM |
2.088uM |
View
|
| sodium channel, voltage-gated, type VII, alpha |
AMITRIPTYLINE |
Sodium Channel, Site 2 |
90% |
2.288uM |
2.088uM |
View
|
| amiloride-sensitive cation channel 5, intestinal |
AMITRIPTYLINE |
Sodium Channel, Site 2 |
90% |
2.288uM |
2.088uM |
View
|
| sodium channel, voltage-gated, type III, beta |
AMITRIPTYLINE |
Sodium Channel, Site 2 |
90% |
2.288uM |
2.088uM |
View
|
| sodium channel, voltage-gated, type VIII, alpha polypeptide |
AMITRIPTYLINE |
Sodium Channel, Site 2 |
90% |
2.288uM |
2.088uM |
View
|
| sodium channel, voltage-gated, type XI, alpha |
AMITRIPTYLINE |
Sodium Channel, Site 2 |
90% |
2.288uM |
2.088uM |
View
|
| sodium channel, voltage-gated, type I, beta |
AMITRIPTYLINE |
Sodium Channel, Site 2 |
90% |
2.288uM |
2.088uM |
View
|
| sodium channel, voltage-gated, type 10, alpha polypeptide |
AMITRIPTYLINE |
Sodium Channel, Site 2 |
90% |
2.288uM |
2.088uM |
View
|
| sodium channel, voltage-gated, type IV, alpha polypeptide |
AMITRIPTYLINE |
Sodium Channel, Site 2 |
90% |
2.288uM |
2.088uM |
View
|
| sodium channel, voltage-gated, type V, alpha polypeptide |
AMITRIPTYLINE |
Sodium Channel, Site 2 |
90% |
2.288uM |
2.088uM |
View
|
| sodium channel, voltage-gated, type II, beta |
AMITRIPTYLINE |
Sodium Channel, Site 2 |
90% |
2.288uM |
2.088uM |
View
|
| sodium channel, nonvoltage-gated 1 alpha |
AMITRIPTYLINE |
Sodium Channel, Site 2 |
90% |
2.288uM |
2.088uM |
View
|
| aldo-keto reductase family 1, member B4 (aldose reductase) |
TANNIC ACID |
Aldose Reductase |
90% |
.346uM |
NoneNone |
View
|
| aldo-keto reductase family 1, member B1 (aldose reductase) |
TANNIC ACID |
Aldose Reductase |
90% |
.346uM |
NoneNone |
View
|
| aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) |
TANNIC ACID |
Aldose Reductase |
90% |
.346uM |
NoneNone |
View
|
| aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) |
TANNIC ACID |
Aldose Reductase |
90% |
.346uM |
NoneNone |
View
|
| adrenergic receptor, alpha 1d (Non-specific probe) |
AMOXAPINE |
Adrenergic alpha1D |
90% |
.306uM |
.15uM |
View
|
| adrenergic receptor, beta 1 |
CLOTRIMAZOLE |
Adrenergic beta1 |
90% |
11.279uM |
6.513uM |
View
|
| adrenergic, beta-1-, receptor |
CLOTRIMAZOLE |
Adrenergic beta1 |
90% |
11.279uM |
6.513uM |
View
|
| progesterone receptor |
CLOTRIMAZOLE |
Progesterone |
90% |
8.774uM |
1.144uM |
View
|
| progesterone receptor |
CLOTRIMAZOLE |
Progesterone |
90% |
8.774uM |
1.144uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
CLOTRIMAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
7.152uM |
4.598uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
CLOTRIMAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
7.152uM |
4.598uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
CLOTRIMAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
7.152uM |
4.598uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
CLOTRIMAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
7.152uM |
4.598uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
CLOTRIMAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
7.152uM |
4.598uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
CLOTRIMAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
7.152uM |
4.598uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
CLOTRIMAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
7.152uM |
4.598uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
CLOTRIMAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
7.152uM |
4.598uM |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
CLOTRIMAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
7.152uM |
4.598uM |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
CLOTRIMAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
7.152uM |
4.598uM |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
CLOTRIMAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
7.152uM |
4.598uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
CLOTRIMAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
7.152uM |
4.598uM |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
CLOTRIMAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
7.152uM |
4.598uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
CLOTRIMAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
7.152uM |
4.598uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
CLOTRIMAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
7.152uM |
4.598uM |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
CLOTRIMAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
7.152uM |
4.598uM |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
CLOTRIMAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
7.152uM |
4.598uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
CLOTRIMAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
7.152uM |
4.598uM |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
CLOTRIMAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
7.152uM |
4.598uM |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
CLOTRIMAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
7.152uM |
4.598uM |
View
|
| cholinergic receptor, muscarinic 5 |
AMIODARONE |
Muscarinic M5 |
90% |
1.499uM |
1.077uM |
View
|
| dopamine receptor D1A |
AMIODARONE |
Dopamine D1 |
90% |
9.142uM |
4.571uM |
View
|
| dopamine receptor 2 |
AMIODARONE |
Dopamine D2L |
90% |
19.952uM |
6.651uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
CHLORPROMAZINE |
Dopamine Transporter |
90% |
2.643uM |
2.1uM |
View
|
| carbonic anhydrase 5a, mitochondrial |
CHLORTHALIDONE |
Carbonic Anhydrase |
90% |
.677uM |
NoneNone |
View
|
| carbonic anhydrase 3 |
CHLORTHALIDONE |
Carbonic Anhydrase |
90% |
.677uM |
NoneNone |
View
|
| carbonic anhydrase 2 |
CHLORTHALIDONE |
Carbonic Anhydrase |
90% |
.677uM |
NoneNone |
View
|
| carbonic anhydrase 4 |
CHLORTHALIDONE |
Carbonic Anhydrase |
90% |
.677uM |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
PROPAFENONE |
Calcium Channel Type L, Phenylalkylamine |
91% |
1.744uM |
1.695uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
PROPAFENONE |
Calcium Channel Type L, Phenylalkylamine |
91% |
1.744uM |
1.695uM |
View
|
| dopamine receptor D4 |
ASTEMIZOLE |
Dopamine D4.2 |
90% |
6.087uM |
2.134uM |
View
|
| opioid receptor, delta 1 |
MONTELUKAST |
Opiate delta |
74% |
4.795uM |
1.69uM |
View
|
| v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
CLOMIPHENE |
Protein Tyrosine Kinase, HER2 Receptor |
90% |
1.669uM |
NoneNone |
View
|
| v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
CLOMIPHENE |
Protein Tyrosine Kinase, HER2 Receptor |
90% |
1.669uM |
NoneNone |
View
|
| progesterone receptor |
SPIRONOLACTONE |
Progesterone |
90% |
1.6654uM |
.2172uM |
View
|
| progesterone receptor |
SPIRONOLACTONE |
Progesterone |
90% |
1.6654uM |
.2172uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2B |
DOXAZOSIN |
Serotonin 5-HT2B |
90% |
.368uM |
.234uM |
View
|
| monoamine oxidase A |
TRIOXSALEN |
Monoamine Oxidase MAOA |
90% |
.831uM |
NoneNone |
View
|
| monoamine oxidase A |
TRIOXSALEN |
Monoamine Oxidase MAOA |
90% |
.831uM |
NoneNone |
View
|
| thromboxane A synthase 1 |
TROGLITAZONE |
Thromboxane Synthetase |
90% |
2.966uM |
NoneNone |
View
|
| thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) |
TROGLITAZONE |
Thromboxane Synthetase |
90% |
2.966uM |
NoneNone |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
LOPERAMIDE |
Calcium Channel Type L, Phenylalkylamine |
90% |
.589uM |
.573uM |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
LOPERAMIDE |
Calcium Channel Type L, Phenylalkylamine |
90% |
.589uM |
.573uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
LOPERAMIDE |
Calcium Channel Type L, Phenylalkylamine |
90% |
.589uM |
.573uM |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
LOPERAMIDE |
Calcium Channel Type L, Phenylalkylamine |
90% |
.589uM |
.573uM |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
LOPERAMIDE |
Calcium Channel Type L, Phenylalkylamine |
90% |
.589uM |
.573uM |
View
|
| adenosine A2a receptor |
RWJ-68354 |
Adenosine A2A |
90% |
1.032uM |
.58uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2C |
RWJ-68354 |
Serotonin 5-HT2C |
90% |
1.237uM |
.648uM |
View
|
| Cytochrom P450-2C19 monooxygenase |
LORATADINE |
CYP450-2C19 Inhibition |
90% |
.016uM |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 |
TROPISETRON |
GABAA, Benzodiazepine, Central |
90% |
1.136uM |
.926uM |
View
|
| gamma-aminobutyric acid A receptor, gamma 1 |
TROPISETRON |
GABAA, Benzodiazepine, Central |
90% |
1.136uM |
.926uM |
View
|
| gamma-aminobutyric acid A receptor, pi |
TROPISETRON |
GABAA, Benzodiazepine, Central |
90% |
1.136uM |
.926uM |
View
|
| AT hook, DNA binding motif, containing 1 (DBSS) |
TROPISETRON |
GABAA, Benzodiazepine, Central |
90% |
1.136uM |
.926uM |
View
|
| gamma-aminobutyric acid A receptor, theta |
TROPISETRON |
GABAA, Benzodiazepine, Central |
90% |
1.136uM |
.926uM |
View
|
| gamma-aminobutyric acid A receptor, gamma 2 |
TROPISETRON |
GABAA, Benzodiazepine, Central |
90% |
1.136uM |
.926uM |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 |
TROPISETRON |
GABAA, Benzodiazepine, Central |
90% |
1.136uM |
.926uM |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 |
TROPISETRON |
GABAA, Benzodiazepine, Central |
90% |
1.136uM |
.926uM |
View
|
| gamma-aminobutyric acid A receptor, alpha 2 |
TROPISETRON |
GABAA, Benzodiazepine, Central |
90% |
1.136uM |
.926uM |
View
|
| adrenergic receptor, beta 1 |
SOTALOL |
Adrenergic beta1 |
73% |
1.4434uM |
.8335uM |
View
|
| gamma-aminobutyric acid A receptor, alpha 1 |
TROPISETRON |
GABAA, Benzodiazepine, Central |
90% |
1.136uM |
.926uM |
View
|
| gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 |
TROPISETRON |
GABAA, Benzodiazepine, Central |
90% |
1.136uM |
.926uM |
View
|
| gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 |
TROPISETRON |
GABAA, Benzodiazepine, Central |
90% |
1.136uM |
.926uM |
View
|
| gamma-aminobutyric acid A receptor, delta |
TROPISETRON |
GABAA, Benzodiazepine, Central |
90% |
1.136uM |
.926uM |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 |
TROPISETRON |
GABAA, Benzodiazepine, Central |
90% |
1.136uM |
.926uM |
View
|
| adrenergic receptor, alpha 2b |
L-744832 |
Adrenergic alpha2C |
90% |
3.136uM |
.456uM |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
L-744832 |
Adrenergic alpha2C |
90% |
3.136uM |
.456uM |
View
|
| cholinergic receptor, muscarinic 2 |
KETOTIFEN |
Muscarinic M2 |
90% |
.838uM |
.298uM |
View
|
| cholinergic receptor, muscarinic 1 |
SERTRALINE |
Muscarinic M1 |
90% |
1.2882uM |
.3102uM |
View
|
| adrenergic receptor, beta 2 |
EPINEPHRINE |
Adrenergic beta2 |
90% |
.284uM |
.196uM |
View
|
| adrenergic receptor, alpha 1d (Non-specific probe) |
NORTRIPTYLINE |
Adrenergic alpha1D |
90% |
.273uM |
.134uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
OXICONAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
1.4711uM |
.9457uM |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
OXICONAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
1.4711uM |
.9457uM |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
OXICONAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
1.4711uM |
.9457uM |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
OXICONAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
1.4711uM |
.9457uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
OXICONAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
1.4711uM |
.9457uM |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
OXICONAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
1.4711uM |
.9457uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
OXICONAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
1.4711uM |
.9457uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
OXICONAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
1.4711uM |
.9457uM |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
OXICONAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
1.4711uM |
.9457uM |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
OXICONAZOLE |
Calcium Channel Type L, Dihydropyridine |
90% |
1.4711uM |
.9457uM |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
CHLORPROMAZINE |
Calcium Channel Type L, Benzothiazepine |
91% |
3.214uM |
2.857uM |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
CHLORPROMAZINE |
Calcium Channel Type L, Benzothiazepine |
91% |
3.214uM |
2.857uM |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
CHLORPROMAZINE |
Calcium Channel Type L, Benzothiazepine |
91% |
3.214uM |
2.857uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
CHLORPROMAZINE |
Calcium Channel Type L, Benzothiazepine |
91% |
3.214uM |
2.857uM |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
CHLORPROMAZINE |
Calcium Channel Type L, Benzothiazepine |
91% |
3.214uM |
2.857uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
CHLORPROMAZINE |
Calcium Channel Type L, Benzothiazepine |
91% |
3.214uM |
2.857uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
CHLORPROMAZINE |
Calcium Channel Type L, Benzothiazepine |
91% |
3.214uM |
2.857uM |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
CHLORPROMAZINE |
Calcium Channel Type L, Benzothiazepine |
91% |
3.214uM |
2.857uM |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
CHLORPROMAZINE |
Calcium Channel Type L, Benzothiazepine |
91% |
3.214uM |
2.857uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
CHLORPROMAZINE |
Calcium Channel Type L, Benzothiazepine |
91% |
3.214uM |
2.857uM |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
CHLORPROMAZINE |
Calcium Channel Type L, Benzothiazepine |
91% |
3.214uM |
2.857uM |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
CHLORPROMAZINE |
Calcium Channel Type L, Benzothiazepine |
91% |
3.214uM |
2.857uM |
View
|
| 5-hydroxytryptamine receptor 6 |
YOHIMBINE |
Serotonin 5-HT6 |
91% |
1.689uM |
.784uM |
View
|
| opioid receptor, sigma 1 |
CISAPRIDE |
Sigma1 |
91% |
.994uM |
.418uM |
View
|
| adrenergic receptor, alpha 2a |
CLOMIPRAMINE |
Adrenergic alpha2A |
91% |
1.414uM |
.53uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
CLOZAPINE |
Calcium Channel Type L, Phenylalkylamine |
91% |
.612uM |
.595uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
CLOZAPINE |
Calcium Channel Type L, Phenylalkylamine |
91% |
.612uM |
.595uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
CLOZAPINE |
Calcium Channel Type L, Phenylalkylamine |
91% |
.612uM |
.595uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
CLOZAPINE |
Calcium Channel Type L, Phenylalkylamine |
91% |
.612uM |
.595uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
CLOZAPINE |
Calcium Channel Type L, Phenylalkylamine |
91% |
.612uM |
.595uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
CLOZAPINE |
Calcium Channel Type L, Phenylalkylamine |
91% |
.612uM |
.595uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
CLOZAPINE |
Calcium Channel Type L, Phenylalkylamine |
91% |
.612uM |
.595uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
CLOZAPINE |
Calcium Channel Type L, Phenylalkylamine |
91% |
.612uM |
.595uM |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
CLOZAPINE |
Calcium Channel Type L, Phenylalkylamine |
91% |
.612uM |
.595uM |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
PROPAFENONE |
Calcium Channel Type L, Phenylalkylamine |
91% |
1.744uM |
1.695uM |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
PROPAFENONE |
Calcium Channel Type L, Phenylalkylamine |
91% |
1.744uM |
1.695uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
PROPAFENONE |
Calcium Channel Type L, Phenylalkylamine |
91% |
1.744uM |
1.695uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
PROPAFENONE |
Calcium Channel Type L, Phenylalkylamine |
91% |
1.744uM |
1.695uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
PROPAFENONE |
Calcium Channel Type L, Phenylalkylamine |
91% |
1.744uM |
1.695uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
PROPAFENONE |
Calcium Channel Type L, Phenylalkylamine |
91% |
1.744uM |
1.695uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
PROPAFENONE |
Calcium Channel Type L, Phenylalkylamine |
91% |
1.744uM |
1.695uM |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
THIORIDAZINE |
Calcium Channel Type L, Benzothiazepine |
91% |
.469uM |
.417uM |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
THIORIDAZINE |
Calcium Channel Type L, Benzothiazepine |
91% |
.469uM |
.417uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
THIORIDAZINE |
Calcium Channel Type L, Benzothiazepine |
91% |
.469uM |
.417uM |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
THIORIDAZINE |
Calcium Channel Type L, Benzothiazepine |
91% |
.469uM |
.417uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
THIORIDAZINE |
Calcium Channel Type L, Benzothiazepine |
91% |
.469uM |
.417uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
THIORIDAZINE |
Calcium Channel Type L, Benzothiazepine |
91% |
.469uM |
.417uM |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
THIORIDAZINE |
Calcium Channel Type L, Benzothiazepine |
91% |
.469uM |
.417uM |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
THIORIDAZINE |
Calcium Channel Type L, Benzothiazepine |
91% |
.469uM |
.417uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
THIORIDAZINE |
Calcium Channel Type L, Benzothiazepine |
91% |
.469uM |
.417uM |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
THIORIDAZINE |
Calcium Channel Type L, Benzothiazepine |
91% |
.469uM |
.417uM |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
THIORIDAZINE |
Calcium Channel Type L, Benzothiazepine |
91% |
.469uM |
.417uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
THIORIDAZINE |
Calcium Channel Type L, Benzothiazepine |
91% |
.469uM |
.417uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
THIORIDAZINE |
Calcium Channel Type L, Benzothiazepine |
91% |
.469uM |
.417uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
THIORIDAZINE |
Calcium Channel Type L, Benzothiazepine |
91% |
.469uM |
.417uM |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
DIMENHYDRINATE |
Calcium Channel Type L, Phenylalkylamine |
78% |
3.344uM |
3.251uM |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
DIMENHYDRINATE |
Calcium Channel Type L, Phenylalkylamine |
78% |
3.344uM |
3.251uM |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
DIMENHYDRINATE |
Calcium Channel Type L, Phenylalkylamine |
78% |
3.344uM |
3.251uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
DIMENHYDRINATE |
Calcium Channel Type L, Phenylalkylamine |
78% |
3.344uM |
3.251uM |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
DIMENHYDRINATE |
Calcium Channel Type L, Phenylalkylamine |
78% |
3.344uM |
3.251uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
DIMENHYDRINATE |
Calcium Channel Type L, Phenylalkylamine |
78% |
3.344uM |
3.251uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
DIMENHYDRINATE |
Calcium Channel Type L, Phenylalkylamine |
78% |
3.344uM |
3.251uM |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
DIMENHYDRINATE |
Calcium Channel Type L, Phenylalkylamine |
78% |
3.344uM |
3.251uM |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
DIMENHYDRINATE |
Calcium Channel Type L, Phenylalkylamine |
78% |
3.344uM |
3.251uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
DIMENHYDRINATE |
Calcium Channel Type L, Phenylalkylamine |
78% |
3.344uM |
3.251uM |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
DIMENHYDRINATE |
Calcium Channel Type L, Phenylalkylamine |
78% |
3.344uM |
3.251uM |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
DIMENHYDRINATE |
Calcium Channel Type L, Phenylalkylamine |
78% |
3.344uM |
3.251uM |
View
|
| cytochrome P450, family 3, subfamily a, polypeptide 13 |
CANDESARTAN |
CYP450-3A4 Inhibition |
78% |
9uM |
NoneNone |
View
|
| cytochrome P450, family 3, subfamily a, polypeptide 13 |
PHENELZINE |
CYP450-3A4 Inhibition |
78% |
2uM |
NoneNone |
View
|
| Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) |
BISACODYL |
CYP450-2C9 Inhibition |
78% |
10uM |
NoneNone |
View
|
| cytochrome P450, family 2, subfamily C, polypeptide 9 |
BISACODYL |
CYP450-2C9 Inhibition |
78% |
10uM |
NoneNone |
View
|
| A3 adenosine receptor |
FLUNARIZINE |
Adenosine A3 |
78% |
5.198uM |
2.938uM |
View
|
| opioid receptor, sigma 1 |
BERBERINE CHLORIDE |
Sigma1 |
78% |
1.289uM |
.542uM |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 |
MEDROXYPROGESTERONE ACETATE |
GABAA, Benzodiazepine, Central |
78% |
7.738uM |
6.305uM |
View
|
| gamma-aminobutyric acid A receptor, gamma 1 |
MEDROXYPROGESTERONE ACETATE |
GABAA, Benzodiazepine, Central |
78% |
7.738uM |
6.305uM |
View
|
| gamma-aminobutyric acid A receptor, pi |
MEDROXYPROGESTERONE ACETATE |
GABAA, Benzodiazepine, Central |
78% |
7.738uM |
6.305uM |
View
|
| AT hook, DNA binding motif, containing 1 (DBSS) |
MEDROXYPROGESTERONE ACETATE |
GABAA, Benzodiazepine, Central |
78% |
7.738uM |
6.305uM |
View
|
| gamma-aminobutyric acid A receptor, theta |
MEDROXYPROGESTERONE ACETATE |
GABAA, Benzodiazepine, Central |
78% |
7.738uM |
6.305uM |
View
|
| gamma-aminobutyric acid A receptor, gamma 2 |
MEDROXYPROGESTERONE ACETATE |
GABAA, Benzodiazepine, Central |
78% |
7.738uM |
6.305uM |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 |
MEDROXYPROGESTERONE ACETATE |
GABAA, Benzodiazepine, Central |
78% |
7.738uM |
6.305uM |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 |
MEDROXYPROGESTERONE ACETATE |
GABAA, Benzodiazepine, Central |
78% |
7.738uM |
6.305uM |
View
|
| gamma-aminobutyric acid A receptor, alpha 2 |
MEDROXYPROGESTERONE ACETATE |
GABAA, Benzodiazepine, Central |
78% |
7.738uM |
6.305uM |
View
|
| gamma-aminobutyric acid A receptor, alpha 1 |
MEDROXYPROGESTERONE ACETATE |
GABAA, Benzodiazepine, Central |
78% |
7.738uM |
6.305uM |
View
|
| gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 |
MEDROXYPROGESTERONE ACETATE |
GABAA, Benzodiazepine, Central |
78% |
7.738uM |
6.305uM |
View
|
| gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 |
MEDROXYPROGESTERONE ACETATE |
GABAA, Benzodiazepine, Central |
78% |
7.738uM |
6.305uM |
View
|
| gamma-aminobutyric acid A receptor, delta |
MEDROXYPROGESTERONE ACETATE |
GABAA, Benzodiazepine, Central |
78% |
7.738uM |
6.305uM |
View
|